MONTELUCASTE GENERIS

Medicinal product

(Invented) name

MONTELUCASTE GENERIS

Active substance (s)

Montelukastas

Strength

5 mg

Pharmaceutical form

kramtomosios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R03DC03, Montelukast

Marketing authorisation holder

UAB Ideal Trade Links, Lietuva

Date of authorisation

2026-10-05

Date of renewal

Documents

3641_3642_MONTELUCASTE GENERIS 4mg_5mg_kramt_tab_PZ_2026-10-05.docx

3642_MONTELUCASTE GENERIS 5mg_kramt_tab_PL_2026-10-05.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Montelukastas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
122473	108583	1108583	lizdinė plokštelė	N14		Receptinis	LT/L/26/3642/001	Netiekiama	-	-	No	-	-
122474	108584	1108584	lizdinė plokštelė	N28		Receptinis	LT/L/26/3642/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2026-10-05	Registruotas